These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 20046686)

  • 21. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.
    Spaide RF; Fisher YL
    Retina; 2006 Mar; 26(3):275-8. PubMed ID: 16508426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis.
    Fallico M; Maugeri A; Lotery A; Longo A; Bonfiglio V; Russo A; Avitabile T; Pulvirenti A; Furino C; Cennamo G; Barchitta M; Agodi A; Reibaldi M
    Acta Ophthalmol; 2021 Sep; 99(6):e795-e805. PubMed ID: 33326183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
    Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
    Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy.
    Alsoudi AF; Wai KM; Koo E; Parikh R; Mruthyunjaya P; Rahimy E
    JAMA Ophthalmol; 2024 Oct; 142(10):972-975. PubMed ID: 39207799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.
    Messias A; Ramos Filho JA; Messias K; Almeida FP; Costa RA; Scott IU; Gekeler F; Jorge R
    Doc Ophthalmol; 2012 Jun; 124(3):225-36. PubMed ID: 22457045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Panretinal Photocoagulation Plus Intravitreal Bevacizumab Versus Panretinal Photocoagulation Alone for Proliferative Diabetic Retinopathy.
    Ali W; Abbasi KZ; Raza A
    J Coll Physicians Surg Pak; 2018 Dec; 28(12):923-927. PubMed ID: 30501828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy.
    Moradian S; Ahmadieh H; Malihi M; Soheilian M; Dehghan MH; Azarmina M
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1699-705. PubMed ID: 18696095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
    di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy.
    Azad AD; Chen EM; Hinkle J; Rayess N; Wu D; Eliott D; Mruthyunjaya P; Parikh R
    Ophthalmol Retina; 2021 Feb; 5(2):151-159. PubMed ID: 32693033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up.
    Arevalo JF; Sanchez JG; Fromow-Guerra J; Wu L; Berrocal MH; Farah ME; Cardillo J; Rodríguez FJ;
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):735-43. PubMed ID: 19189118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).
    Jorge R; Costa RA; Calucci D; Cintra LP; Scott IU
    Retina; 2006; 26(9):1006-13. PubMed ID: 17151487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.
    Cho WB; Oh SB; Moon JW; Kim HC
    Retina; 2009 Apr; 29(4):516-22. PubMed ID: 19262436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of choroidal thickness after treatment for diabetic retinopathy.
    Lee SH; Kim J; Chung H; Kim HC
    Curr Eye Res; 2014 Jul; 39(7):736-44. PubMed ID: 24502275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.
    Arevalo JF; Maia M; Flynn HW; Saravia M; Avery RL; Wu L; Eid Farah M; Pieramici DJ; Berrocal MH; Sanchez JG
    Br J Ophthalmol; 2008 Feb; 92(2):213-6. PubMed ID: 17965108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy.
    Cho WB; Moon JW; Kim HC
    Br J Ophthalmol; 2010 Jul; 94(7):858-63. PubMed ID: 20606024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence effect in the treatment of proliferative diabetic retinopathy with intravitreal ranibizumab and panretinal photocoagulation.
    Cao G; Xu X; Wang C; Zhang S
    Eur J Ophthalmol; 2020 Jan; 30(1):34-39. PubMed ID: 30539668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.